Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Encres Dubuit (ALDUB.PA)
Mitry-Mory, FR
Encres Dubuit, a company founded in Mitry-Mory, France, in 1970, operates as a global specialist in the development, manufacture, and sale of advanced technical and industrial inks. Their product portfolio supports a variety of printing technologies, including screen, pad, and digital methods. Beyond manufacturing, the firm provides expert services such as precise color matching and management, complemented by robust technical support. These highly versatile ink solutions are integral to a vast array of applications, from everyday items like cards, labels, and packaging to specialized uses in optical discs, touch panels, security features, household appliances, glasses, membrane switches, and signage. Furthermore, Encres Dubuit's products are extensively utilized across diverse industries, notably automotive, electronics, beverages, and textiles.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +3.00% | -13.45% | -17.60% | -11.21% | -14.17% | -27.97% | -45.79% | -47.18% | -24.26% | -88.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.2% Q4'25: -15.8% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-266.7% Q4'25: -191.9% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-8.8% Q4'25: +1.9% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%-12.7% Q4'25: -15.3% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%-19.3% Q4'25: -43.6% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%0.0% Q4'25: +3.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-1.20× Q4'25: -0.51× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
25.81M
est.
|
24.24M
est.
|
25.23M
est.
|
21.37M
est: 21.60M (-1.1%)
|
21.00M
est: 20.40M (+2.9%)
|
22.31M
est: 22.20M (+0.5%)
|
24.57M
est: 23.70M (+3.7%)
|
23.58M
est: 23.60M (-0.1%)
|
18.64M
est: 18.60M (+0.2%)
|
20.68M
est: 20.70M (-0.1%)
|
22.72M
est: 22.10M (+2.8%)
|
19.94M
est: 20.48M (-2.7%)
|
20.19M
est: 21.10M (-4.3%)
|
17.72M
est: 21.90M (-19.1%)
|
| EBITDA |
661.8K
est.
|
609.2K
est.
|
634.2K
est.
|
3.00M
est: 553.8K (+441.1%)
|
2.40M
est: 523.1K (+359.8%)
|
1.85M
est: 569.2K (+225.4%)
|
2.43M
est: 607.7K (+299.2%)
|
1.21M
est: 605.1K (+100.5%)
|
590.0K
est: 476.9K (+23.7%)
|
2.16M
est: 530.8K (+307.5%)
|
1.18M
est: 566.7K (+108.6%)
|
-1.29M
est: 115.5K (-1,217.4%)
|
95.0K
est: 119.0K (-20.2%)
|
-1.21M
est: 123.6K (-1,080.2%)
|
| EBIT |
-678.1K
est.
|
-624.3K
est.
|
-649.9K
est.
|
2.31M
est: -567.5K (+507.1%)
|
1.62M
est: -536.0K (+403.0%)
|
1.19M
est: -583.3K (+304.4%)
|
1.75M
est: -622.7K (+380.6%)
|
401.0K
est: -620.0K (+164.7%)
|
-477.0K
est: -488.7K (+2.4%)
|
1.23M
est: -543.8K (+326.0%)
|
138.0K
est: -580.6K (+123.8%)
|
-2.34M
est: -984.1K (-137.4%)
|
-1.23M
est: -1.01M (-21.4%)
|
-2.26M
est: -1.05M (-114.4%)
|
| Net Income |
1.88M
est.
|
1.33M
est.
|
740.5K
est.
|
864.0K
est: 364.8K (+136.8%)
|
1.32M
est: 486.4K (+171.1%)
|
834.0K
est: 1.19M (-29.7%)
|
1.26M
est: 912.0K (+38.4%)
|
257.0K
est: 243.2K (+5.7%)
|
-554.0K
est: -1.02M (+45.8%)
|
905.0K
est: -281.5K (+421.5%)
|
-171.0K
est: 91.2K (-287.5%)
|
-2.23M
est: -1.57M (-42.4%)
|
-1.19M
est: -395.1K (-201.7%)
|
-4.36M
est: 2.25M (-293.7%)
|
| SGA |
7.66M
est.
|
7.08M
est.
|
7.34M
est.
|
—
est: 6.41M (-100.0%)
|
6.76M
est: 6.05M (+11.6%)
|
7.24M
est: 6.59M (+9.9%)
|
7.48M
est: 7.03M (+6.4%)
|
7.39M
est: 7.00M (+5.6%)
|
6.97M
est: 6.60M (+5.5%)
|
7.35M
est: 6.14M (+19.7%)
|
8.08M
est: 6.56M (+23.2%)
|
—
est: 4.55M (-100.0%)
|
8.06M
est: 8.99M (-10.4%)
|
—
est: 4.86M (-100.0%)
|
| EPS |
0.62
est.
|
0.44
est.
|
0.25
est.
|
0.28
est: 0.12 (+133.3%)
|
0.44
est: 0.16 (+175.0%)
|
0.27
est: 0.39 (-30.8%)
|
0.42
est: 0.30 (+40.0%)
|
0.09
est: 0.08 (+6.9%)
|
-0.18
est: -0.34 (+46.4%)
|
0.30
est: -0.09 (+424.0%)
|
-0.06
est: 0.03 (-287.3%)
|
-0.71
est: -0.52 (-37.6%)
|
-0.39
est: -0.13 (-200.0%)
|
-1.43
est: 0.74 (-293.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yann Hamelin | Research & Development Director and Member of the Executive Board | 77.5K | male |
| Alexandra Taulin | Chairman of the Management Board | — | female |
| Pierre Blaix | Member of Management Board & Director of Strategy Development | — | male |
| Veronique Guguen | Member of Management Board | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALDUB.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
